Medication-assisted Treatment (MAT) Market Trends

  • Report ID: 5814
  • Published Date: Mar 05, 2024
  • Report Format: PDF, PPT

Medication-assisted Treatment (MAT) Market Trends

Growth Drivers

  • Increase in Substance Abuse Deaths- Drug overdose deaths have been increasing rapidly and are among one of the reasons for mortality across the globe. According to the World Health Organization, about 600000 deaths were attributed to drug use in the year 2019. In addition, the rise in substance abuse deaths catalyzes the recognizing the urgency of implementing evidence-based interventions like MAT, leading to increased acceptance, adoption, and growth in the medication-assisted treatment market.  Furthermore, substance abuse often coexists with mental health disorders, contributing to the complexity of treatment. MAT, by addressing both addiction and mental health aspects, becomes a comprehensive solution that stimulates the market.
  • Rising Awareness of Medication-assisted Treatment (MAT)- Health organizations and advocacy groups conduct public education campaigns to spread information about the effectiveness of MAT in treating substance use disorder. In addition, increased media coverage of substance abuse issues and the role of MAT in treatment amplifies awareness. News stories, documentaries, and interviews with experts influence public opinion and encourage individuals to seek medication-assisted treatment when facing addiction challenges which stimulates the market. Furthermore, positive testimonials and success stories from individuals who have benefited from MAT contribute to the growth of the medication-assisted treatment market.   
  • Emergence of Technological Innovation- The integration of digital health tools, such as mobile applications and web platforms, facilities remote monitoring and management of patients undergoing MAT. In addition, the adoption of teleheath services has expanded access to MAT, allowing patients to consult with healthcare professionals virtually. This is particularly valuable for individuals in remote areas which boosts the medication-assisted treatment market. Furthermore, electronic health records systems streamline the management of patient information, ensuring that healthcare providers have comprehensive and up-to-date records. This promotes coordinated care, reduces administrative burdens, and enhances the overall quality of MAT programs.

Challenges

  • Regulatory Challenges across Regions- Regulatory framework and licensing requirements vary across regions, posing challenges to the expansion of medication-assisted treatment services. Integration and harmonization of the regulation process are necessary to overcome these obstacles.
  • Unequal distribution of healthcare resources, particularly in rural and low-income areas, restricts access to medication-assisted treatment.
  • The stigma linked with substance addiction and MAT is a significant hurdle to its adoption. Moreover, the lack of awareness among the general public regarding the implementation of MAT is also a hindrance.

Medication-assisted Treatment (MAT) Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

 ~ 11.4%

Base Year Market Size (2023)

~ USD 13.3 Million

Forecast Year Market Size (2036)

~ USD 24.7 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5814
  • Published Date: Mar 05, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increase in substance abuse deaths, rising awareness of Medical –assisted Treatment (MAT) and emergence of technological innovations are the major factors driving the growth of the medication-assisted treatment market.

The market size of medication-assisted treatment is anticipated to attain a CAGR of 11.4% over the forecast period, i.e., 2024 - 2036.

The major players in the market are Orexo AB, Novartis AG, Mylan N.V., Lupin Limited, Hikma Pharmaceuticals PLC and others.

The drug type segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample